2BB score and signals
Spero Therapeutics, Inc.’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 59 | Normal |
| Quality | 40 | Normal |
| Risk | 42 | Moderate |
Company facts
| Founded | 2013 |
| Employees | 25 |
| P/E ratio | 7.16 |
| 52-week range | $1.08 – $3.08 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.1632 | — | — |
| 2026-08-12 | — | -0.1734 | — | — |
| 2026-05-13 | -0.13 | -0.1836 | $260,000.00 | — |
| 2026-03-26 | 0.53 | -0.204 | $41.30M | $0.00 |
Related companies
